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The diagnostic considerations raised by immunocompromised patients with opportunistic
infection continue to expand. When such patients harbor latent or persistent infection acquired in
a tropical environment, thediagnosticchallenge is even greater. The Infectious Disease Service at
Yale-New Haven Hospital was asked to see a middle-aged man from Peru with known T-cell
lymphoma who had recently completed a course of chemotherapy. He presented to the hospital
with fever, petechial skin rash, pulmonary infiltrates, and neutropenia. Ultimately this case
illustrated the necessity for careful evaluation ofsuch patients, looking, in particular, for evidence
ofopportunistic parasitic infection.
CASE PRESENTATION
DR. CHARLES BERENSON (Infectious Disease Fellow): A 58-year-old Peruvian man was
admitted to Yale-New Haven Hospital with new pulmonary infiltrates, fever, and a
petechial rash, which occurred two weeks after completing a course of chemotherapy
for lymphoma.
He first presented to us in October 1984, with unusual skin lesions, diagnosed by
skin biopsy as manifestations of polyarteritis nodosa. He was treated with prednisone
and cyclophosphamide through December 1984. There was no previous history of
active tuberculosis, but a chest radiograph taken at that time (Fig. lA) showed
questionable apical scarring. Multiple sputum examinations were negative for acid-
fast organisms. Hematocrit was 42.8 percent; white blood count was 15.8/mm3, with
11 percent eosinophils, prompting evaluation of two stool specimens for ova and
parasites. Both were negative. By February 1985, he had returned with massive
lymphadenopathy, pancytopenia, and fever. Lymph node biopsies demonstrated a
stage IV T-cell lymphoma. He completed a course of cyclophosphamide, adriamycin,
vincristine, and prednisone (CHOP) fourteen days prior to admission. Two days prior
to admission he developed tachypnea and a cough productive of blood-streaked
sputum. Abdominal discomfort gradually developed and was treated with antacids and
cimetidine. On the day of admission he became lethargic and febrile. Emergency
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FIG. 1. A. Previous chest
radiograph obtained in De-
> l cember 1984. Questionable
apical scarring is shown, but
no other abnormalities were
i 1 } noted. B. Chest radio-
graph taken during current
admission. New bilateral
diffuse pulmonary infiltrates
are present.
. . ~~~.0W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~......il.....;
medical technicians administered intravenous fluids to correct a blood pressure of
50/30, and rapidly transported him to Yale-New Haven Hospital. The patient had
worked as a field laborer in Peru and was most recently employed in a local hotel
kitchen. He had no history oftravel since emigrating from Peru in February 1984.
On admission he was arousable and appropriate, with a temperature of 102.40F, a
blood pressure of90/60, a pulse of 140/minute, and a respiratory rate of 30/minute.
He had pale conjunctivae, palpable cervical lymphadenopathy, and a supple neck.
Bibasilar rales were heard, but cardiac examination was unremarkable. Diminished
bowel sounds and mild, diffuse, epigastric tenderness were noted. A non-blanching
petechial rash containing a few pustules was noted on his abdomen. Stool did not
contain occult blood. The chest radiograph taken on admission showed bilateral
pulmonary infiltrates (Fig. 1B).
DR. MARY JEAN AHERN (Associate Clinical Professor ofMedicine): There are diffuse
interstitial infiltrates, most prominent in the lower lobes. Although diffuse, they do not
resemble miliary tuberculosis. Evidence ofcongestive heart failure is not present since
neither cardiomegaly nor increased vascular markings have appeared since the
previous radiograph.
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DR. BERENSON: Laboratory values included a hemoglobin of 4.7 gm/dl, hematocrit of
14.2 percent, plateletcount of 189,000/,ul, and awhiteblood countof 1,100/,ul, with 37
polymorphonuclear leukocytes, 15 bands, 36 lymphocytes, 10 monocytes, and 2
metamyelocytes. Chemistries included serum sodium concentration 129 meq/L,
potassium 5.0 meq/L, chloride 94 meq/L, CO2 24.6 meq/L, blood urea nitrogen 25
mg/dl, and creatinine 1.1 mg/dl. Transaminase (SGOT) was 92 IU (normal, less than
40), but other liver function parameters were normal. Prothrombin time was 13.2
seconds (control, 11.5 seconds) and partial thromboplastin time was two minutes.
Arterial blood gas values obtained with the patient breathing room air were pH 7.57,
PCO2 23 torr, P02 39 torr, which rose to 7.50, 27 torr, and 101 torr, respectively, while
he received 100 percent oxygen by mask. He was intubated because of persistent
respiratory distress.
Skin lesions were biopsied by the dermatology consultants. Their differential
diagnosis included leukocytoclastic angiitis, septic vasculitis, and disseminated intra-
vascular coagulation (DIC). Gram stain ofskin pustule contents demonstrated neither
bacterial organisms nor cells.
APHYSICIAN: His rash could represent meningococcemia. Although one might explain
his lethargy by anemia and/or anoxia, a lumbar puncture would be indicated.
DR.BERENSON: A lumbar puncture was performed and showedclearcerebrospinal fluid
with no white blood cells, four red blood cells, and normal glucose and-protein
concentrations.
DR. THOMAS GRECO (Assistant Clinical Professor ofMedicine): Was there any known
exposure to ticks? Rocky Mountain spotted fever or another rickettsial disease within
the spotted fever or typhus group could cause shock, a petechial rash, and pulmonary
infiltrates.
DR. BERENSON: He had no known exposure to ticks or wooded areas.
DR. FRANK BIA (Associate Professor ofMedicine): Epidemiologically, that would be
very important information. In addition, endemictyphus from exposure to rat fleas has
been seen in the United States in restaurant and food workers. Was there any evidence
ofdisseminated intravascular coagulation?
DR. BERENSON: His platelet count remained normal. Measurement of fibrin degrada-
tion products and review of peripheral blood smear did not suggest that DIC was
occurring.
DR.GRECO: His hematocrit dropped enough that one must be concerned about either a
hemolytic event or a bleeding diathesis. His peripheral blood smear did not suggest
hemolysis, however, and his stool showed no evidence of occult gastrointestinal
bleeding. That brings up the possibility of retroperitoneal bleeding, which unfortu-
nately would not explain either his dermatological or pulmonary processes.
DR. BERENSON: Abdominal ultrasound examination and computerized tomographic
scans showed no evidence ofretroperitoneal bleeding, although retroperitoneal lymph-
adenopathy was present. Following blood transfusions, his hematocrit remained
stable.
DR.AHERN: I would like to direct this discussion toward consideration ofhispulmonary
infiltrates. While his neutrophil count wasslightly above 500/,ul, we must still consider
those opportunistic infections which affect neutropenic patients.
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FIG. 2. Wet mount of
sputum shown under low
power. Motile filariform lar-
>7 ~~~~~~~~~~~vae ofStrongyloides sterco-
ralis are present.
DR. ROBERT BALTIMORE (Associate Professor ofPediatrics andEpidemiology): While
bacterial pneumonias commonly infect neutropenic patients, the diffuse nature of
these infiltrates makes a bacterial pneumonia less likely. This pattern is more
suggestive ofPneumocystis cariniipneumonia [1]. In addition, lymphoma patients can
develop diffuse infiltrates as a result ofcytomegalovirus or Herpes zoster infections.
DR. GRECO: Legionella pneumonia has also been described in this setting and deserves
consideration. Mycoplasma pneumoniae is not a common cause of pneumonia in
compromised hosts, but the diffuse pattern makes it worth considering. Both possibili-
ties should be covered by including erythromycin in any empiric antibiotic coverage
used while awaiting results ofdiagnostic tests.
DR.JOHN MELLORS (Assistant ProfessorofMedicine): Fungal infections have not been
commented upon. Most commonly Candida, and Aspergillus, but also Mucor species,
are recognized causes of fungal pneumonia in neutropenic patients [2]. Usually,
Aspergillus pneumonia presents as wedge-shaped infiltrates; however, diffuse infil-
trates are possible. Diagnosis of these entities might require bronchoscopy or an
open-lung biopsy, but I would like to know the results ofa sputum Gram stain first.
DR. BERENSON: Endotracheal suctioning yielded modest amounts of blood-tinged
pulmonary secretions. Occasional inflammatory cells were seen scattered among some
larger unidentifiable Gram-variable objects, thought at first to represent mucous
plugs. Acid-fast and potassium hydroxide preparations were not helpful. The patient
was started empirically on antibiotics which included mezlocillin, an aminoglycoside,
erythromycin, and trimethoprim-sulfamethoxazole to cover the range of clinical
possibilities raised thus far in our discussion. Sputum was sent for Legionella direct
fluorescent antibody staining, viral cultures, bacterial cultures, and both acid-fast and
silver stains; however, a wet mount of sputum revealed the material shown in Fig. 2.
These objects were best seen under low power. They were clearly mobile and readily
identified as filariform larvae ofthe nematode, Strongyloides stercoralis.
DR. BIA: At this point, the previous sputum Gram stain was re-evaluated. Under low
power, the large Gram-variable objects seen in the sample were recognized as
filariform larvae (Fig. 3) albeit somewhat obscured by the stain. It is a mistake to
overlook performing low-power evaluation of Gram-stained specimens. Had a more
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FIG. 3. Gram stain of
sputum shown under low
power. Strongyloides filari-
form larvae are noted. Or-
ganism was no longer motile
* ~~~~~~~and displayed Gram-vani- - ~~~~~~~~~~~~~~~able staining along its outer
margin.
careful low-power evaluation of this specimen been done, the organisms might have
been identified on Gram stain. The utility of Gram stains for diagnosis of pulmonary
strongyloidiasis has recently been reported [3]. Still, their appearance and motility
makes their identification on a wet preparation ofsputum somewhat easier.
The absence of peripheral eosinophilia should not preclude this diagnosis. It is
taught that disseminated strongyloidiasis, and other parasitic infections, commonly
present with eosinophilia. In fact, even patients with overwhelming disseminated
strongyloidiasis who are not neutropenic often demonstrate eosinopenia [4].
DR. BERENSON: An interesting laboratory finding was noted by the lab technicians
responsible for working on the patient's sputum culture. The growth pattern of
Staphylococcus aureus in the culture seemed to follow tiny serpiginous tracks caused
by movement of the larvae through the agar, a laboratory phenomenon recently
reported by others [5,6].
Histological examination of skin biopsies was largely unremarkable; however, in a
few sections, larvae were visible near dermal blood vessels (Fig. 4). The patient was
FIG. 4. Skin biopsy shown
under high power. Biopsy of
petechial lesion revealed a
longitudinally sectioned
nematode (large arrow)
present near a dermal blood
vessel (small arrow).
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FIG. 5. Stool examined
for ova and parasites showed
,, large numbers of strongy-
lobides filariform larvae,
jf,which can be distinguished
¾ from hookworm by their
small buccal cavities (ar-
row).
begun on thiabendazole, 3 grams/day, via a nasogastric tube. Antibacterial coverage
with mezlocillin and an aminoglycoside agent was continued.
DR. MELLORS: Although a clear-cut bacterial infection was not demonstrated, it would
be appropriate to maintain coverage for enteric organisms under these circumstances.
In disseminated strongyloidiasis, enteric flora may reach the circulation by larval
disruption ofthe bowel wall, or possibly by being "piggy-backed" across the gut on or
within the migrating larvae. Hematogenous spread of bacteria can result in systemic
bacterial infection such as pneumonia or Gram-negative bacillary meningitis [7].
DR. BERENSON: In fact, on the ninth day of hospitalization, he became more lethargic,
and meningismus was present. A repeat lumbar puncture revealed cloudy cerebrospi-
nal fluid with 480 red blood cells/,ul and 220 white blood cells/,ul (99 percent
polymorphonuclear leukocytes). Protein and glucose concentrations remained normal;
Gram stain, cryptococcal antigen determination, and India ink preparation were
negative. Cultures yielded nogrowth. As Dr. Mellors has suggested, a partially treated
meningitis of enteric origin was suspected, although cases of central nervous system
strongyloidiasis have also been reported [8]. After several days of therapy with
parenteral cefotaxime, 12 grams/day, cerebrospinal fluid pleocytosis resolved.
Partial ileus and large gastric residual volumes made administration of thiabenda-
zole difficult, interrupting therapy. As the ileus improved, stool specimens showed
enormous numbers of filariform larvae (Fig. 5). Therapy with thiabendazole was
continued over 25 days, until stool and sputum specimens were free oflarvae.
During therapy, bilirubin and transaminase levels rose. Possible causes included
thiabendazole toxicity, recurrent lymphoma, or hepatic larval infiltration. Rapidly
worsening lymphadenopathy represented failure to induce remission ofthe underlying
lymphoma. Further attempts at chemotherapy were considered unwise. Despite
improvement ofhis parasitic infection, hesuccumbed to his malignancy after six weeks
ofhospitalization. A post-mortem examination was not performed.
DISCUSSION
DR. BERENSON: We can summarize the life cycle of this interesting nematode in the
following manner. Free-living Strongyloides stercoralis adults live in the soil where
their ova hatch into rhabditiform larvae. These larvae undergo several moults and
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become invasive filariform larvae, which can penetrate the skin of humans to cause
local cutaneous lesions, called larvae currens. Larvae then enter the lymphatic system
and travel through veins to the right heart and lungs, where they pentrate into alveolar
spaces. They are coughed up and swallowed, arriving at the duodenum and proximal
jejunum. Filariform larvae than burrow into gut mucosa, where they develop into
adults. Each female lays about 40 eggs per day. Ova then hatch into rhabditiform
larvae, which are expelled with feces [4].
DR. BIA: In contrast to other nematode infections such as hookworm, one almost never
finds S. stercoralis ova in the stool of patients with strongyloidiasis. One finds larvae
instead. Finding filariform larvae in feces is one means of distinguishing between
Strongyloides stercoralis infections and those caused by other nematodes [9]. If,
however, a stool sample contains hookworm ova and sits for a period of time before
being examined, the- ova can hatch. The larvae are difficult to distinguish from
Strongyloides larvae, which have a somewhat shorter buccal cavity than do hookworm
larvae (Fig. 5).
DR. BERENSON: Iffilariform larvae actually develop within the gut, they may reinvade it
or penetrate the perianal skin to reinfect the same host in a process called autoinfec-
tion. Occasionally, a large number of larvae become invasive and produce a heavy
nematode burden for the infected host. This is referred to as the "hyperinfection
syndrome." It may include gastrointestinal problems such as nausea, vomiting, and
diarrhea, and respiratory complaints such as wheezing and hemoptysis [7].
Scowden et al. distinguish this from "disseminated strongyloidiasis," in which
autoinfection is profound and large numbers of filariform larvae disseminate to many
organs including liver, central nervous system, heart, lymph nodes, and kidneys. Both
brain and meningeal involvement have been documented. Hepatic invasion, while
unusual, is suggested by elevations of bilirubin and/or alkaline phosphatase [4].
Both of these syndromes overlap considerably, each predisposing to bacteremia
caused by enteric organisms. The lungs and meninges are sites of metastatic bacterial
infections. Damage to intestinal lymphatics causes bowel edema, malabsorption, and
ileus, making therapy of this illness with the currently available oral medication
(thiabendazole) somewhat difficult.
About half of all patients with intestinal strongyloidiasis have no symptoms
referable to the infection. Most ofthe remainder have only vague or mild gastrointesti-
nal complaints. Patients with intact cell-mediated immunity do not progress to develop
either dissemination or hyperinfection. Many conditions predispose to disseminated
strongyloidiasis, including lymphomas, treated leukemias, renal transplantation, sys-
temic lupus erythematosus, and nephrotic syndrome. Depressed cell-mediated immun-
ity may also result from alcoholism, chronic renal failure, malnutrition, and carci-
nomas, in addition to chemotherapeutic agents which depress cell-mediated immunity
[4,10].
During autoinfection, transformation from rhabditiform to filariform larvae occurs
in the gut. Corticosteroids may encourage penetration ofthe gut wall by reducing local
inflammation [4]. In addition, autoinfection is enhanced by azathioprine and cyclo-
phosphamide. While it has been assumed that cyclosporine A might produce a similar
predisposition, experimental evidence in rats suggests that it might actually protect
against strongyloidiasis [1I1 ].
Clinical observations suggest an important defensive role for eosinophils and
antibodies against S. stercoralis larvae. Patients with severe intestinal infections have
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been noted to have lower serum IgG levels and lower eosinophil counts than their
asymptomatic counterparts [12]. In another study, immunosuppressed patients with
strongyloidiasis, including some with disseminated disease, all had elevated IgG levels.
Hyperinfected patients had lower IgE levels, however, as well as lower eosinophil
counts than did non-hyperinfected patients. While not conclusive, a possible protective
role for IgE and eosinophils is suggested [13].
Current therapy for uncomplicated intestinal strongyloidiasis is a two-day course of
thiabendazole (25 mg/kg twice a day for twodays; maximum, 3 g/day), which is given
orally. It is the only recommended medication for disseminated disease. Cambenda-
zole, a thiabendazole derivative, may be superior for intestinal strongyloidiasis [14],
but it has not been evaluated for efficacy against disseminated disease and is not
readily available in the U.S. The duration oftherapy for disseminated disease is not at
all clear, but a minimum of five days' therapy is suggested. Repeated stool examina-
tions are probably the best parameter of successful therapy. One should remove, if
possible, those factors responsible for compromising cell-mediated immunity, such as
immunosuppressive drugs.
The complicated course followed by our patient clearly illustrates several of the
issues discussed. He manifested both the hyperinfection state and disseminated
strongyloidiasis and probably suffered from enteric bacteremia with bacterial seeding
of the meninges. The latter seems more likely than meningeal infection by nematodes
since cerebrospinal fluid pleocytosis rapidly resolved with antibacterial therapy. His
elevated serum bilirubin and transaminase, with normal alkaline phosphatase levels, is
uncharacteristic ofhepatic infection by nematodes.
Exposure to S. stercoralis larvae need not have been in the recent past. Laboratory
evaluations performed in veterans of World War II have demonstrated persistent
strongyloidiasis acquired during their 1940s military service in southeast Asia [15,16].
This casedictates a need tosearch exhaustively for intestinal evidenceofstrongyloidia-
sis in asymptomatic patients from endemic areas, particularly if eosinophilia exists,
prior to institution ofimmunosuppressive therapy.
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